Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol. 2020 Mar 9. pii: S1470-2045(19)30862-9. doi: 10.1016/S1470-2045(19)30862-9.
Lancet Oncol. 2020 Mar 9. pii: S1470-2045(19)30862-9. doi: 10.1016/S1470-2045(19)30862-9.
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700)
Oncology. 2020 Jul 6;1-8. doi: 10.1159/000507733.
Oncology. 2020 Jul 6;1-8. doi: 10.1159/000507733.
Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study
Oral Oncology Volume 97, Pages 99-104. doi: 10.1016/j.oraloncology.2019.08.019. Epub 2019 Aug 28.
Oral Oncology Volume 97, Pages 99-104. doi: 10.1016/j.oraloncology.2019.08.019. Epub 2019 Aug 28.
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials
Eur J Cancer . 2020 Jun 15;135:78-88. doi: 10.1016/j.ejca.2020.04.045. Online ahead of print.
Eur J Cancer . 2020 Jun 15;135:78-88. doi: 10.1016/j.ejca.2020.04.045. Online ahead of print.
Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer
Journal of Clinical Oncology 38, no. 28 (October 01, 2020) 3314-3324. doi: 10.1200/JCO.20.01225.
Journal of Clinical Oncology 38, no. 28 (October 01, 2020) 3314-3324. doi: 10.1200/JCO.20.01225.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO
British Journal of Cancer (2020). https://doi.org/10.1038/s41416-020-01089-9
British Journal of Cancer (2020). https://doi.org/10.1038/s41416-020-01089-9
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapyda pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest
European Journal of Cancer (2020). DOI:https://doi.org/10.1016/j.ejca.2020.08.009
European Journal of Cancer (2020). DOI:https://doi.org/10.1016/j.ejca.2020.08.009
Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study
ESMO Open 2020;5:e000876. doi:10.1136/esmoopen-2020-000876
ESMO Open 2020;5:e000876. doi:10.1136/esmoopen-2020-000876